Glutamate Dehydrogenase as a Promising Target for Hyperinsulinism Hyperammonemia Syndrome Therapy.
Curr Med Chem. 2022;29(15):2652-2672. doi: 10.2174/0929867328666210825105342.
Curr Med Chem. 2022.
PMID: 34525914